Senate Health Panel To Hold User Fee Hearing With FDA Heads April 26

By Kelly Lienhard / April 20, 2022 at 3:21 PM
The Senate health committee on April 26 will hold its second user fee reauthorization hearing with testimony from the heads of FDA’s drug, biologics and device centers, Patrizia Cavazzoni, Peter Marks and Jeff Shuren, respectively, committee Chair Patty Murray (D-WA) announced Wednesday (April 20) . Murray said the hearing will focus on how to advance medical product regulation and innovations that benefit patients. During its first user fee hearing on April 5, members of the committee heard from the drug,...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.